PO.CH01.06 · 化学
Antibodies, Antibody-Drug Conjugates, and Nucleic Acids
- 2393 2393 DXC016:一种新型cMET靶向双载荷抗体偶联药物,展现出强效抗肿瘤活性和有利于皮下给药的药代动力学 DXC016, a novel cMET-targeting dual payload antibody-drug conjugate, demonstrates potent antitumor activity and favorable PK for potential subcutaneous use Yong Du, Jiaojiao Yu, Huihui Guo, Lingli Zhang, Xiaoqiang Xie, Jialei Hu, Xiafen Wu, Yunxia Zheng, Yuanyuan Huang, Junxiang Jia, Wei Liu, Zhouyang Zhou, Qingliang Yang, Robert Y. Zhao
- 2394 2394 一种新型2+2 IgG样双特异性抗体偶联药物,靶向EBV GP220/350和EGFR,用于鼻咽癌的选择性治疗 A novel 2+2 IgG-like bispecific antibody-drug conjugate targeting EBV GP220/350 and EGFR for selective treatment of nasopharyngeal carcinoma Saihong Yu, Yunxia Zheng, Junxiang Jia, Xiangfei Kong, Juan Wang, Yi Luo, Hangbo Ye, Xueqing Ma, Qingliang Yang, Robert Y. Zhao
-
2395 · PDF DXC011:一种靶向叶酸受体α的新型双载荷抗体偶联药物 DXC011, a novel dual-payload antibody-drug conjugate targeting folate receptor alpha Zhicang Ye, Huihui Guo, Wei Zheng, Junpeng Wang, Yifang Xu, Hui Xia, Yuanyuan Huang, Junxiang Jia, Wei Liu, Xiang Chen, You Zhou, Qingliang Yang, Robert Y. Zhao
- 2396 2396 一种新型携带双载荷的2+2 IgG样双特异性抗体偶联药物,用于异质性胃肠道癌症的靶向治疗 A novel 2+2 IgG-like bispecific antibody-drug conjugate with dual payloads for targeted therapy of heterogeneous gastrointestinal cancers Wei Zheng, Junxiang Jia, Xiaolei Liu, Gengxiang Zhao, Yongxiang Chen, Xia Zhou, Simin Zhao, Qingliang Yang, Robert Y. Zhao
-
2397 · PDF 基于细胞的载荷释放揭示了双载荷ADC中依赖于设计、位点和细胞的比例偏移 Cell based payload release highlights design, site, and cell dependent ratio shifts in dual payload ADCs Nan Hsuan Wang, Wei-Han Lee, Evelyn He, Li Chuan Huang, Yu-Chao Huang, David Teng-Yi Huang, Ya-Chi Chen
-
2398 · PDF 剖析ADC肺毒性:一种用于指导和启示ADC发现的小鼠ADC相关ILD模型 Dissecting ADC pulmonary toxicity: A murine ADC-associated ILD model to guide and inform ADC discovery Suresh Anaganti, Arti Bhujade, Steven Murkli, Zachary Sparta, Nabin Panth, Alexander Weig, Richa Vartak, Julien Dugal-Tessier, Nareshkumar Jain
- 2399 2399 ZL-6201的发现:一种用于治疗肉瘤和上皮性实体瘤的新型靶向LRRC15的抗体药物偶联物(ADC) Discovery of ZL-6201, a novel LRRC15-targeting antibody drug conjugate (ADC) for the treatment of sarcomas and epithelial solid tumors He Xu, Zengxia Li, Jiaqing Yi, Wilson Peng, Qiuping Ye, Xinchao Xia, Lei Wang, Xinchuan Dai, Yue Ge, Donghui Li, Ziruo Wen, Changwei Lv, Joshua Zeng, Qidong Hu, Lina Wang, Jelveh Lameh, Nathan Ihle, Bing Wan, Linda N. Liu
-
2400 · PDF 用作抗体药物偶联物载荷的mRNA翻译抑制剂的设计与评估 Design and evaluation of mRNA translation inhibitors for use as antibody drug conjugate payloads Mark Petersen, Jodi Wong, Samir Das, Vidhi Khanna, Kurt Stahl, Micheal G. Brant, Truman Hirkala-Schaefer, Jesse Leblanc, Victoria K. Harman-McKenna, Manuel Lasalle, Graham A. E. Garnett, Rehan Higgins, Catalina Suarez, Kaylee J. Wu, Linglan Fu, Germanna Righetto, Devika Sim, Adele Chan, Allysha Bissessur, Ambroise Wu, Araba Sagoe-Wagner, Luying Yang, Andrea Hernandez Rojas, Dunja Urosev, Sam Lawn, Vincent Fung, Stuart D. Barnscher, Raffaele Colombo, Jamie R. Rich
- 2401 2401 开发单B细胞平台以加速抗体发现与筛选 Developing a single B cell platform to accelerate antibody discovery and screening Spencer Chiang, Wenlin Ren, An Ouyang, Yu Sun, Xiaoli Li
-
2402 · PDF 利用Pioneer抗体发现平台快速生成先导物 Rapid lead generation with the Pioneer Antibody Discovery Platform Birthe Jessen-Park, Sarah-Jane Kellmann, Mateusz Putyrski, Manuel Cavada, Hanh Hanuschka, Christian Frisch, Achim Knappik, Francisco Ylera
-
2403 · PDF 通过创新的生物偶联和连接子架构策略推进精准肿瘤学 Advancing precision oncology through innovative bioconjugation and linker architecture strategies Shuhui Chen, Dan Hart, Matt Giese, Erika Leonard, Bowu Luan, Shamali Roy, Michael Fiebig, Catherine Bladen
-
2404 · PDF 新型核酸药物介导的选择性肿瘤免疫激活 Selective tumor immune activation by novel nucleic acid drug Akimitsu Okamoto, Kunihiko Morihiro, Makoto Yamamoto
-
2405 · PDF 一种同类首创的IKZF1/3降解剂抗体偶联物(DAC)作为潜在的骨髓瘤治疗药物 A first-in-class IKZF1/3 degrader antibody conjugate (DAC) as a potential myeloma treatment Shuai Wu, Jinyu Yang, Mo Dan, Xiwu Hui, Bing Yao, Miaomiao Wei, Bin Bao, Qiwen Zhu, Linlin Xiao, Penghui Wen, Xiaodan Zhang, Wei Fang, Xiao Li
- 2406 2406 一种新型BRD4降解剂-HER2靶向抗体药物偶联物(DAC)克服HER2阳性癌症中的德曲妥珠单抗(trastuzumab deruxtecan)耐药 A novel BRD4 degrader-HER2-targeting antibody-drug conjugate (DAC) overcomes trastuzumab deruxtecan resistance in HER2-positive cancers Xin Yu, Bin Yang, Wendi Ni, Haibo Liu, Jan Willem Theunissen, Jesse Chen, Jin Wang
-
2407 · PDF DAC-1522:一种用于精准肿瘤治疗的新型Trop2靶向降解剂-抗体偶联物 DAC-1522: A novel Trop2-targeting degrader-antibody conjugate for precision oncology Chuanjie Chen, Qianqian Shen, Xinhui Cai, Yaqi Ding, Xiaoyu Yang, Yanfen Fang, Carlos Chai, Jian Ding, Yi Chen, Xuan Zhang
-
2408 · PDF ADC在癌症治疗中的应用:基于SPR的发现与表征洞见 ADCs in cancer treatment: SPR-driven insights into discovery and characterization Soraya Diez-Posada, Cynthia Shuman, Narashima Murthy Bandaru, Anna Moberg, Bryan Edwards, Sam Ness, Lowri Davies, Anja Pomowski, Laura Bouché, Isabel Perez-Castro, Howard Desmond, Gokhan Yahioglu, Mahendra P. Deonarain